Gland Pharma and Neuland Laboratories have entered into a long-term strategic contract development and manufacturing organisation (CDMO) partnership to strengthen their presence in the fast-growing sterile active pharmaceutical ingredient (API) segment. As part of the collaboration, Gland Pharma will establish a dedicated sterile manufacturing suite for APIs used in microparticle depot products at its JNPC […]